Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...

Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

Importantly, higher CTC counts correlated with measures of prostate cancer severity, including PSA levels, numbers of metastases in bone, and other indicators. "This research emphasizes the ...

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate ...

A HEALTHY 78-year-old man went to his dentist with a wobbly lower left pre-molar, hoping for a quick fix. After evaluating the situation, the dentist decided the best course of action was to ...

Scientists at MedUni Vienna, led by Lukas Kenner, have made a groundbreaking discovery that could change how we understand ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...

Further tests, such as CT scans and bone scans, may be performed to determine whether prostate cancer has spread. Management strategies for prostate cancer should be guided the severity of the ...